Diffuse Myocardial Fibrosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-03-17
Clinical Trial Update: Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease [Phase 2]
A Phase 2 trial is evaluating losartan for diffuse myocardial fibrosis in patients with sickle cell disease and is currently recruiting.